| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-09 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-09 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-08 |